Latest in News & Research

Cutaneous Immune-Related AEs Linked to Survival After ICI Therapy

Improved survival associated with cirAEs for patients receiving anti-programmed cell death 1 or anti-programmed cell death ligand 1 therapy

By Dermsquared Editorial Team | | January 12, 2022

Depression Up in Pediatric, Adult Hidradenitis Suppurativa Patients

Prevalence of depression increased among adults and children with hidradenitis suppurativa

By Physician’s Briefing Staff | | January 12, 2022

Pfizer Says Omicron-Specific Vaccine Ready by March

Pfizer also working to improve its current COVID-19 vaccine 'to address any future variant of potential concern, if needed'

By Physician’s Briefing Staff | | January 12, 2022

Severe COVID-19 Outcomes Rare After Primary Vaccination

Risk higher for people who were aged 65 years or older, immunosuppressed, or had at least one of six underlying conditions

By Physician’s Briefing Staff | | January 10, 2022

Relatlimab-Nivolumab Ups PFS in Untreated Advanced Melanoma

Combination provides greater benefit than nivolumab alone for progression-free survival in untreated metastatic or unresectable melanoma

By Physician’s Briefing Staff | | January 06, 2022

Secukinumab Beneficial for Psoriatic Arthritis, Concomitant Plaque Psoriasis

Significantly more patients receiving secukinumab versus adalimumab achieved PASI 100 response at week 52

By Dermsquared Editorial Team | | January 05, 2022

How Satisfied Are Patients With Clinic-Based Hidradenitis Suppurativa Surgery?

Despite recurrence, most patients with hidradenitis suppurativa are very satisfied with their surgical results

By Dermsquared Editorial Team | | January 05, 2022

Antibiotic Choices for Skin, Soft Tissue Infections Vary by Race

Compared with White inpatients, Black inpatients less likely to receive cefazolin, more likely to receive clindamycin for SSTIs

By Physician’s Briefing Staff | | January 05, 2022

Serious Adverse Effects From COVID-19 Vaccines Reported Rarely

Full vaccination dose, younger age, female sex, and previously having had COVID-19 linked to greater odds of adverse effects

By Physician’s Briefing Staff | | January 05, 2022

Atopic Dermatitis Exacerbations Seen in Premenstrual Period

Worsening reported in eczema area and severity index score, numerical rating scale worst itch, and dermatology life quality index

By Physician’s Briefing Staff | | January 05, 2022

Scientists Spot Clues to Why Omicron Infections Are Milder

More than a dozen research groups have been observing the omicron variant in lab settings using animals this past month

By Physician’s Briefing Staff | | January 03, 2022

Is Ultrasonography More Sensitive for Detecting Metastases in High-Risk SCC?

Baseline ultrasonography more sensitive for detecting lymph node metastases than clinical examination alone

By Dermsquared Editorial Team | | December 29, 2021

Is Apremilast Efficacious, Safe for Mild-to-Moderate Psoriasis?

Significantly greater response rate seen in static Physician Global Assessment at week 16 for apremilast versus placebo

By Dermsquared Editorial Team | | December 29, 2021

High-Fiber Diet May Benefit Melanoma Patients on Immunotherapy

Higher intake of dietary fiber linked to longer progression-free survival in melanoma patients on immune checkpoint blockade

By Physician's Briefing Staff | | December 28, 2021

Spesolimab Clears Lesions in Generalized Pustular Psoriasis

In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions

By Physician’s Briefing Staff | | December 27, 2021

AI Allows Automated Scoring of Psoriasis Area, Severity

Conventional neural networks have the potential to automatically perform image-based Psoriasis Area and Severity Index scoring

By Physician’s Briefing Staff | | December 24, 2021

Botox Injections Linked to Lower Incidence of Anxiety Symptoms

Protective effect of BoNT found for different indications, including in cosmetic use/facial muscles, migraine/facial and head muscles

By Physician’s Briefing Staff | | December 23, 2021

Are Novel Inflammatory Markers Prognostic for Mortality in Epidermal Necrolysis?

Red cell distribution width to hemoglobin ratio shows similar predictive ability to SCORTEN; better discrimination with composite

By Dermsquared Editorial Team | | December 22, 2021

What Factors Impact Treatment Outcomes in Psoriasis?

Patients on TNFi or IL-17i have lower odds of achieving treatment outcomes with comorbid obesity and history of diabetes

By Dermsquared Editorial Team | | December 22, 2021

Serum Biomarkers Can Differentiate Psoriatic Arthritis, RA

Panel of serum protein biomarkers identified and evaluated for potential use in diagnostic testing for early-onset psoriatic arthritis

By Physician’s Briefing Staff | | December 21, 2021

Freedom From Disease' in Psoriasis Is Multicomponent Concept

Definition includes five domains of management of clinical symptoms, psychosocial elements, QoL, treatment, health care team support

By Physician’s Briefing Staff | | December 20, 2021

Does Dupilumab Provide Sustained Control of Atopic Dermatitis?

Dupilumab can help patients achieve adequate disease control and reduce use of other therapies

By Dermsquared Editorial Team | | December 15, 2021

COVID-19 Severity Does Not Differ for Patients With Skin Conditions

Acute COVID-19 and its treatment can impact the course of skin disease in vitiligo, psoriasis, atopic dermatitis, chronic urticaria

By Physician’s Briefing Staff | | December 15, 2021

24 of 1292

Headline from the Week of October 19 - 25, 2026

The Distance Between Habit and Strategy

By Dermsquared Editorial Team | | October 23, 2026

From Poster to Practice: The Control Gap in CIndU

| October 23, 2026